| 000 | 01153 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250513205211.0 | ||
| 264 | 0 | _c20000322 | |
| 008 | 200003s 0 0 eng d | ||
| 022 | _a1170-7690 | ||
| 024 | 7 |
_a10.2165/00019053-200017010-00001 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWade, W E | |
| 245 | 0 | 0 |
_aFormulary management of low molecular weight heparins. _h[electronic resource] |
| 260 |
_bPharmacoEconomics _cJan 2000 |
||
| 300 |
_a1-12 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aCost-Benefit Analysis |
| 650 | 0 | 4 | _aEconomics, Pharmaceutical |
| 650 | 0 | 4 | _aFormularies as Topic |
| 650 | 0 | 4 |
_aHeparin, Low-Molecular-Weight _xeconomics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aPostoperative Complications _xprevention & control |
| 650 | 0 | 4 |
_aVenous Thrombosis _xprevention & control |
| 700 | 1 | _aMartin, B C | |
| 700 | 1 | _aKotzan, J A | |
| 700 | 1 | _aSpruill, W J | |
| 700 | 1 | _aChisoholm, M A | |
| 700 | 1 | _aPerri, M | |
| 773 | 0 |
_tPharmacoEconomics _gvol. 17 _gno. 1 _gp. 1-12 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2165/00019053-200017010-00001 _zAvailable from publisher's website |
| 999 |
_c10701168 _d10701168 |
||